Jazz Pharmaceuticals (JAZZ) PT Lowered to $180 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq set for higher open as oil prices extend declines, midterm results awaited
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 228.85 +14.41 (6.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.44 | 52 Week High | $160.00 | |||
| Open | $225.37 | 52 Week Low | $95.80 | |||
| Day High | $230.21 | P/E | 42.54 | |||
| Day Low | $218.53 | EPS | $5.38 | |||
| Volume | 159,891 | |||||
